Related Experiment Video
Updated: May 24, 2026

07:46
Platform for Quantitative Detection of Endometrial Immune Cells Based on Immunohistochemistry and Digital Image Analysis
Published on: October 13, 2023
[Recurrent pregnancy loss--evaluation and treatment]
Asher Bashiri1, Shaked Gete, Moshe Mazor
1Department of Obstetrics, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel. abashiri@bgu.ac.il
Harefuah
|March 21, 2012
Summary
Women experiencing recurrent pregnancy loss (RPL) face complex evaluations, often with negative results. Specialized clinics offer a 75% live birth rate for these women, improving outcomes and reducing psychological distress.
Area of Science:
- Reproductive Medicine
- Genetics
- Endocrinology
Context:
- Recurrent pregnancy loss (RPL) presents diagnostic challenges, with ~50% of workups yielding no definitive cause.
- Patients with RPL experience significant psychological distress, including anxiety and depression.
- Evolving definitions and evaluation methods for RPL necessitate updated clinical approaches.
Purpose:
- To review current diagnostic and therapeutic strategies for recurrent pregnancy loss (RPL).
- To discuss recent advancements in understanding RPL pathophysiology and etiology.
- To highlight the management of RPL within a specialized clinic setting.
Summary:
- Standard RPL evaluation includes parental karyotyping, uterine anatomy assessment, hormonal profiling (TSH, prolactin, glucose), and antiphospholipid antibody (APLA) evaluation.
- Recent literature shows changes in RPL definition, uterine cavity assessment, and the role of antithrombotic therapy in idiopathic RPL.
- New insights into RPL pathophysiology and etiology are expanding the scope of patient evaluation.
Impact:
- Women with RPL, particularly idiopathic RPL, achieve approximately a 75% live birth rate in specialized RPL clinics.
- This review provides an overview of RPL management based on recent studies and clinical experience at Soroka University Medical Center.
- Understanding updated RPL concepts can lead to improved patient counseling and treatment outcomes.
Related Concept Videos
Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
